CD34+ cells obtained from "good mobilizers" are more activated and exhibit lower ex vivo expansion efficiency than their counterparts from "poor mobilizers"

Transfusion

Volumn 50, Issue 1, 2010, Pages 120-127

  Ivanovic, Zoran ^a,b,c,d   Kovacevic Filipovic, Milica ^a,b,c,d   Jeanne, Michel ^a,b,c,d   Ardilouze, Leslie ^a,b,c,d   Bertot, Anne ^a,b,c,d   Szyporta, Milène ^a,b,c,d   Hermitte, Francis ^a,b,c,d   Lafarge, Xavier ^a,b,c,d   Duchez, Pascale ^a,b,c,d   Vlaski, Marija ^a,b,c,d   Milpied, Noel ^a,b,c,d   Pavlovic, Mirjana ^a,b,c,d   Praloran, Vincent ^a,b,c,d   Boiron, Jean Michel ^a,b,c,d  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b FLORIDA ATLANTIC UNIVERSITY   (United States)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; OXYGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

AIR; APOPTOSIS; ARTICLE; CD34 SELECTION; CELL CULTURE; CELL CYCLE G0 PHASE; CELL EXPANSION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; COLONY FORMING CELL; CYTAPHERESIS; EX VIVO STUDY; FOLLOW UP; HUMAN; HYPOTHERMIA; KINETICS; METABOLISM; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PURIFICATION;

ANTIGENS, CD34; APOPTOSIS; CARBON DIOXIDE; CELL DIVISION; CELL SURVIVAL; CRYOPRESERVATION; ENERGY METABOLISM; G0 PHASE; G1 PHASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; OXYGEN;

EID: 73649115656     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02436.x     Document Type: Article

References (21)

1. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995 86 : 3961 9.
2. Lemoli RM, Tafuri A, Fortuna A, Petrucci MT, Ricciardi MR, Catani L, Rondelli D, Fogli M, Leopardi G, Ariola C, Tura S. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood 1997 89 : 1189 96.
3. Lemoli RM, D'Addio A. Hematopoietic stem cell mobilization. Haematologica 2008 l93 : 321 4 Review).
4. Gazitt Y, Shaughnessy P, Liu Q. Expression of adhesion molecules on CD34(+) cells in peripheral blood of non-Hodgkin's lymphoma patients mobilized with different growth factors. Stem Cells 2001 19 : 134 43. (Pubitemid 32222238)
5. + cells in mobilized peripheral blood of non-Hodgkin's lymphoma patients. Stem Cells 2001 19 : 37 45. (Pubitemid 32057970)
6. 0 CD34+/CD38-/low severe combined immunodeficiency repopulating cells. Stem Cells 2005 23 : 561 74.
7. Ratajczak MZ, Reca R, Wysoczynski M, Yan J, Ratajczak J. Modulation of the SDF-1-CXCR4 axis by the third complement component (C3) - implications for trafficking of CXCR4 stem cells. Exp Hematol 2006 34 : 986 95.
8. Avdalovic M, Fong D, Formby B. Adhesion and costimulation of proliferative responses of human gamma delta T cells by interaction of VLA-4 and VLA-5 with fibronectin. Immunol Lett 1993 35 : 101 8.
9. 1 versus S+G2/M phases of the cell cycle. Blood 1998 92 : 842 8.
10. Perez-Oteyza J, Ramos P, Testa N, Heinrichs B, Lopez-Jimenez J, Garcia-Laraña J, Odriozola J. High-dose granulocyte-colony stimulating factor (G-CSF) in vitro induces the growth of high proliferative potential colony forming cells (HPP-CFC) in patients undergoing blood stem cell mobilization. Exp Hematol 1997 25 : 516 20.
11. Ivanovic Z, Bartolozzi B, Antonio-Bernabei P, Cipolleschi MG, Milenkovic P, Praloran V, Sbarba PD. A simple, one-step clonal assay allows the sequential detection of committed (CFU-GM-like) and of several subsets of primitive (HPP-CFC) murine progenitors. Stem Cells 1999 17 : 219 25.
12. Jeanne M, Bouzgarrou R, Lafarge X, Fizet D, Dazey B, Vezon G, Ivanovic Z. Comparison of CD34+ cell collection on the CS-3000+ and Amicus blood cell separators. Transfusion 2003 43 : 1423 7.
13. Jeanne M, Kovacevic-Filipovic M, Szyporta M, Vlaski M, Hermitte F, Lafarge X, Duchez P, Boiron JM, Praloran V, Ivanovic Z. Low oxygen and high carbon dioxide atmosphere improves the conservation of hematopoietic progenitors in hypothermia. Transfusion 2009 49 : 1738 46.
14. Hermitte F, Brunet de la Grange P, Belloc F, Praloran V, Ivanovic Z. Very low O2 concentration (0.1%) favors G0 return of dividing CD34+ cells. Stem Cells 2006 24 : 65 73.
15. Ivanovic Z, Duchez P, Morgan DA, Hermitte F, Lafarge X, Chevaleyre J, Praloran V, Dazey B, Vezon G, Boiron JM. Whole-blood leukodepletion filters as a source of CD34+ progenitors potentially usable in cell therapy. Transfusion 2006 46 : 118 25.
16. Duchez P, Dazey B, Douay L, Vezon G, Ivanovic Z. An efficient large-scale thawing procedure for cord blood cells destined for selection and ex vivo expansion of CD34+ cells. J Hematother Stem Cell Res 2003 12 : 587 9.
17. Reiffers J, Cailliot C, Dazey B, Attal M, Caraux J, Boiron JM. Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells. Lancet 1999 354 : 1092 3.
18. Ivanovic Z, Duchez P, Dazey B, Hermitte F, Lamrissi-Garcia I, Mazurier F, Praloran V, Reiffers J, Vezon G, Boiron JM. A clinical-scale expansion of mobilized CD34+ hematopoietic stem and progenitor cells by using a new serum-free medium. Transfusion 2006 46 : 126 31.
19. 1 of the cell cycle and express higher levels of amphotropic retrovirus receptor mRNA. Exp Hematol 1999 27 : 1160 7.
20. Fruehauf S, Veldwijk MR, Krämer A, Haas R, Zeller WJ. Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cells from steady-state bone marrow and peripheral blood mobilized following G-CSF-supported chemotherapy. Stem Cells 1998 16 : 271 9.
21. Boiron JM, Dazey B, Caillot C, Launay B, Attal M, Mazurier F, McNiece IK, Ivanovic Z, Caraux J, Marit G, Reiffers J. The ex vivo expansion of CD34+ cells allows prediction of neutropenia abrogation after autologous transplantation without impairing the long term engraftment capacity. Transfusion 2006 46 : 1934 42.